PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35242574-7	2022	Levels of the axonal damage marker Neurofilament light (NF-L) were highly elevated in both GM2 and GM1 gangliosidosis patient plasma samples, with no overlap with controls.	gm2	91-94	neurofilament light chain	Homo sapiens	56-60	
35242574-9	2022	In GM2 gangliosidosis patient plasma NF-L, Tau, GFAP and lysoGM2 were all most highly elevated in infantile onset patients, indicating a relationship to severity and phenotype.	gm2	3-6	neurofilament light chain	Homo sapiens	37-41	
35242574-11	2022	These results indicate that lysosphingolipids and NF-L/GFAP have potential to monitor pharmacodynamics and pathogenic processes respectively in GM2 and GM1 gangliosidoses patients.	gm2	144-147	neurofilament light chain	Homo sapiens	50-54